Variant report
Variant | nsv968963 |
---|---|
Chromosome Location | chr5:97548970-97550079 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:97549671-97549705 | GM20000 | blood: | n/a | n/a |
2 | POLR2A | chr5:97549457-97549568 | Gliobla | brain: | n/a | n/a |
3 | POLR2A | chr5:97548799-97548999 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | POLR2A | chr5:97549589-97549617 | Gliobla | brain: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:97546193..97548925-chr5:97549441..97552160,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238000 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557275322 | chr5:97549009-97549010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565600849 | chr5:97549014-97549015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376769040 | chr5:97549046-97549047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370623163 | chr5:97549058-97549059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561382735 | chr5:97549086-97549087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114045619 | chr5:97549095-97549096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554689877 | chr5:97549120-97549121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557527122 | chr5:97549122-97549123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192230453 | chr5:97549127-97549128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149929927 | chr5:97549128-97549129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs61733886 | chr5:97549136-97549137 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs577959343 | chr5:97549137-97549138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536734252 | chr5:97549213-97549214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371748796 | chr5:97549223-97549224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62366814 | chr5:97549285-97549286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565065412 | chr5:97549286-97549287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530840095 | chr5:97549291-97549292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112688572 | chr5:97549300-97549301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560746497 | chr5:97549311-97549312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4535477 | chr5:97549366-97549367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546418007 | chr5:97549377-97549378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571503833 | chr5:97549410-97549411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368637960 | chr5:97549474-97549475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550769653 | chr5:97549488-97549489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569181812 | chr5:97549505-97549506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536572551 | chr5:97549562-97549563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556946384 | chr5:97549606-97549607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554933737 | chr5:97549638-97549639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190813711 | chr5:97549642-97549643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534299587 | chr5:97549645-97549646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559049669 | chr5:97549646-97549647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148740000 | chr5:97549651-97549652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573576205 | chr5:97549668-97549669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557214058 | chr5:97549669-97549670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181954467 | chr5:97549678-97549679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542587383 | chr5:97549818-97549819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13171183 | chr5:97549869-97549870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548927644 | chr5:97549895-97549896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540226456 | chr5:97549911-97549912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564595859 | chr5:97549963-97549964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377596560 | chr5:97549968-97549969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532100146 | chr5:97549969-97549970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529995120 | chr5:97549972-97549973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568791059 | chr5:97550020-97550021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562777381 | chr5:97550030-97550031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370623265 | chr5:97550037-97550038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530410969 | chr5:97550039-97550040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548651385 | chr5:97550043-97550044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567159780 | chr5:97550046-97550047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6860681 | chr5:97550067-97550068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21611746 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:97540400-97551800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:97548400-97549000 | Weak transcription | Fetal Muscle Leg | muscle |
3 | chr5:97549000-97549200 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr5:97549000-97549800 | Enhancers | Fetal Muscle Trunk | muscle |
5 | chr5:97549000-97551600 | Enhancers | HSMMtube | muscle |
6 | chr5:97549200-97550200 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr5:97549200-97550800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr5:97549200-97551400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr5:97549400-97550800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr5:97549400-97551000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr5:97549400-97551200 | Enhancers | HSMM | muscle |
12 | chr5:97549400-97551200 | Enhancers | Osteobl | bone |
13 | chr5:97549600-97551000 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr5:97549600-97551000 | Enhancers | NHEK | skin |
15 | chr5:97550000-97551000 | Enhancers | NHDF-Ad | bronchial |